Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway

BACKGROUND: Acute myeloid leukemia (AML) is initiated and maintained by a subset of self-renewing leukemia stem cells (LSCs), which contribute to the progression, recurrence and therapeutic resistance of leukemia. However, the mechanisms underlying the maintenance of LSCs drug resistance have not be...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi, Chen, Hai-xuan, Zhou, Shu-yan, Wang, Shao-xiang, Zheng, Kai, Xu, Dan-dan, Liu, Yu-ting, Wang, Xiao-yan, Wang, Xiao, Yan, Hai-zhao, Zhang, Li, Liu, Qiu-ying, Chen, Wan-qun, Wang, Yi-fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357193/
https://www.ncbi.nlm.nih.gov/pubmed/25890196
http://dx.doi.org/10.1186/s12943-015-0326-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357193/
https://www.ncbi.nlm.nih.gov/pubmed/25890196
http://dx.doi.org/10.1186/s12943-015-0326-0

Ejemplares similares